BioMerieux to pay $450M for infectious disease Dx firm

France-based bioMerieux has agreed to buy BioFire Diagnostics, maker of the PCR FilmArray used to detect infectious diseases, for $450 million plus debt. The deal, set to be finalized at the close of the fiscal year or early next year, is expected to allow bioMerieux to bolster its presence in the infectious disease testing arena.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA